Immunoglobulin gene mutations and frequent use of VH1-69 and VH4-34 segments in hepatitis C virus-positive and hepatitis C virus-negative nodal marginal zone B-cell lymphoma

American Journal of Pathology

Volumn 159, Issue 1, 2001, Pages 253-261

  Marasca, Roberto ^a   Vaccari, Paola ^a   Luppi, Mario ^a   Zucchini, Patrizia ^a   Castelli, Ilaria ^a   Barozzi, Patrizia ^a   Cuoghi, Angela ^a   Torelli, Giuseppe ^a,b  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

IGK; IMMUNOGLOBULIN; IMMUNOGLOBULIN HEAVY CHAIN;

ARTICLE; B CELL LYMPHOMA; GENE REARRANGEMENT; GENETICS; HEPATITIS C VIRUS; HUMAN; IMMUNOGLOBULIN VARIABLE REGION; ISOLATION AND PURIFICATION; MOLECULAR GENETICS; MUTATION; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; POLYMERASE CHAIN REACTION; VIROLOGY;

BASE SEQUENCE; GENE REARRANGEMENT; HEPACIVIRUS; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOGLOBULIN VARIABLE REGION; IMMUNOGLOBULINS; LYMPHOMA, B-CELL; MOLECULAR SEQUENCE DATA; MUTATION; POLYMERASE CHAIN REACTION;

EID: 0035403970     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)61691-4     Document Type: Article

References (50)

1. Harris NL, Jaffe ES, Stein H, Banks PM, Chan JKC, Cleary ML, Delsol G, De Wolf-Peeters C, Falini B, Gatter KC, Grogan TM, Isaacson PG, Knowles DM, Mason DY, Muller-Hermelink HK, Pileri SA, Piris MA, Ralfkiaer E, Warnke RA: A revised European-American classification of the lymphoid neoplasms. A proposal from the International Lymphoma Study Group. Blood 1994, 84:1361-1392
2. Jaffe ES, Harris NL. Diebold J, Muller Hermelink HK: World Health Organization classification of neoplastic disease of the hematopoietic and lymphoid tissues. Am J Clin Pathol 1999, 111(suppl 1):S8-S12
3. Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J, Lister TA, Bloomfield CD: World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the clinical advisory committee meeting - Airlie House, Virginia, November, 1997. J Clin Oncol 1999, 17:3835-3849
4. Nathwani BN, Anderson JR, Armitage JO, Cavalli F, Diebold J, Drachenberg MR, Harris NL, MacLennan KA, Müller-Hermelink HK, Ullrich FA, Weisenburger DD: Marginal zone B-cell lymphoma: a clinical comparison of nodal and mucosa-associated lymphoid tissue types. J Clin Oncol 1999, 17:2486-2492
5. Agnello V, Chung RT, Kaplan LM: A role of hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med 1992, 327:1490-1495
6. Pozzato G, Mazzero C, Crovatto M, Modolo ML, Ceselli S, Mazzi G, Sul faro S, Franzin F, Tulissi P, Moretti M: Low-grade malignant lymphoma, hepatitis C virus infection and mixed cryoglobulinemia. Blood 1994, 84:3047-3053
7. Ferri C, Caracciolo F, Zignego AL, La Civita L, Monti M, Longobardo G, Lombardini F, Greco F, Capochiani E, Mazzoni A, Mazzaro C, Pasero GP: Hepatitis C virus infection in patients with non-Hodgkin's lymphoma. Br J Haematol 1994, 88:392-394
8. Silvestri F, Pipan C, Barillari G, Zaja F, Fanin R, Infanti L, Russo D, Falasca E, Botta GA, Baccarani M: Prevalence of hepatitis C virus infection in patients with lymphoproliferative disorders. Blood 1996, 87:4296-4301
9. Luppi M, Ferrari MG, Bonaccorsi G, Longo G, Narni F, Barozzi P, Marasca R, Mussini C, Torelli G: Hepatitis C virus infection in subsets of neoplastic lymphoproliferations not associated with cryoglobulinemia. Leukemia 1996, 10:351-355
10. Zuckerman E, Zuckerman T, Levine AM, Douer D, Gutekunst K, Mizokami M, Qian DG, Velankar M, Nathwani BN, Fong TL: Hepatitis C virus infection in patients with B-cell non-Hodgkin lymphoma. Ann Intern Med 1997, 127:423-428
11. Hyjek E, Isaacson PG: Primary B-cell lymphoma of the thyroid and its relationship to Hashimoto's thyroiditis. Hum Pathol 1988, 9:1315-1326
12. Hyjek E, Smith WJ, Isaacson PG: Primary B-cell lymphoma of salivary glands and its relationship to myoepithelial sialadenitis. Hum Pathol 1988, 19:766-776
13. Wotherspoon AC, Ortiz-Hildago C, Falzon MF, Isaacson PG: Helico-bacter pylori-associated gastritis and primary B-cell gastric lymphoma. Lancet 1991, 338:1175-1176
14. Wotherspoon AC, Doglioni C, Diss TC, Pan L, Moschini A, De Boni M, Isaacson PG: Regression of primary low-grade B-cell gastric lymphoma of mucosa associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet 1993, 342:575-577
15. Roggero E, Zucca E, Pinotti G, Pascarella A, Capella C, Savio A, Pedrinis E, Paterlini A, Venco A, Cavalli F: Eradication of Helicobacter pylori infection in primary low-grade gastric lymphoma of mucosa associated lymphoid tissue. Ann Intern Med 1995, 122:767-769
16. Du M, Diss TC, Xu C, Peng H, Isaacson PG, Pan L: Ongoing mutation in MALT lymphoma immunoglobulin gene suggest that antigen stimulation plays a role in the clonal expansion. Leukemia 1996, 10:1190-1197
17. Yumoto N, Furukawa M, Kurosu K, Mikata A: A particular characteristic of IgH complementary-determining region 3 suggests autoreactive B-cell origin of primary gastric B-cell lymphomas. Lab Invest 1998, 78:261-268
18. Tierens A, Delabie J, Pittaluga S, Driessen A, De Wolf-Peeters C: Mutation analysis of the rearranged immunoglobulin heavy chain genes of marginal zone lymphomas indicate an origin from different marginal zone B lymphocytes subsets. Blood 1998, 91:2381-2386
19. Bahler DW, Miklos JA, Swerdlow SH: Ongoing Ig hypermutation in salivary gland mucosa-associated lymphoid tissue-type lymphomas. Blood 1997, 89:3335-3344
20. Cook GP, Tomlinson IM: The human immunoglobulin VH repertoire. Immunol Today 1995, 16:237-242
21. Chang B, Casali P: The CDR1 sequences of a major proportion of human germline Ig VH genes are inherently susceptible to amino acid replacement. Immunol Today 1994, 15:367-373
22. Kuppers R, Klein U, Hansmann ML, Rajewsky K: Cellular origin of human B-cell lymphomas. N Engl J Med 1999, 341:1520-1529
23. Kuppers R, Hajadi M, Plank L, Rajewsky K, Hansmann ML: Molecular Ig gene analysis reveals that monocytoid B cell lymphoma is a malignancy of mature B cells carrying somatically mutated V region genes and suggest that rearrangement of the kappa-deleting element (resulting in deletion of the Ig kappa enhancer) abolish somatic hypermutation in the human. Eur J Immunol 1996, 26:1794-1800
24. Dorner T, Brezinschek H-P, Brezinschek RI, Foster SJ, Domiati-Saad R, Lipsky PE: Analysis of the frequency and pattern of somatic mutations within non productively rearranged human variable heavy chain genes. J Immunol 1997, 158:2779-2789
25. Dorner T, Brezinschek H-P, Foster SJ, Brezinschek RI, Farner NL, Lipsky PE: Delineation of selective influences shaping the mutated expressed human Ig heavy chain repertoire. J Immunol 1998, 160: 2831-2841
26. Brezinschek HP, Brezinschek RI, Lipsky PE: Analysis of the heavy chain repertoire of human peripheral B cells using single-cell polymerase chain reaction. J Immunol 1995, 155:190-202
27. Hsu FJ, Levy R: Preferential use of the VH4 Ig gene family by diffuse large-cell lymphoma. Blood 1995, 86:3072-3082
28. Thompsett AR, Ellison DW, Stevenson FK, Zhu D: VH gene sequences from primary central nervous system lymphomas indicate derivation from highly mutated germinal center B cell with ongoing mutational activity. Blood 1999, 94:1738-1746
29. Montesinos-Rongen M, Kuppers R, Schluter D, Spieker T, van Roost D, Schaller C, Reifenberger G, Wiestler OD, Deckert-Schluter M: Primary central nervous system lymphomas are derived from germinal-center B cells and show a preferential usage of the VH4-34 gene segment. Am J Pathol 1999, 155:2077-2085
30. Fais F, Ghiotto F, Hashimoto S, Sellars B, Valetto A, Allen SL, Schulman P, Vinciguerra VP, Rai K, Rassenti LZ, Kipps TJ, Dighiero G, Schroeder Jr HW, Ferrarini M, Chiorazzi N: Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptor. J Clin Invest 1998, 102:1515-1525
31. Pascual V, Capra JD: VH4-21, a human VH gene segment over-represented in the autoimmune repertoire. Arthritis Rheum 1992, 35:11-18
32. Rettig MB, Vescio RA, Cao J, Wu CH, Lee JC, Han E, DerDanielian M, Newman R, Hong C, Lichtenstein AK, Berenson JR: VH gene usage in multiple myeloma: complete absence of the VH4.21 (VH4-34) gene. Blood 1996, 87:2846-2852
33. Pascual V, Victor K, Spellerberg M, Hamblin TJ, Stevenson FK, Capra JD: VH restriction among human cold agglutinins. The VH4-21 gene segment is required to encode anti-I and anti-i specificities. J Immunol 1992, 149:2337-2344
34. Silberstein LE, Jefferies LC, Goldman J, Friedman D, Moore JS, Nowell PC, Roelcke D, Pruzanski W, Roudier J, Silverman GJ: Variable region gene analysis of pathologic human autoantibodies to the related i and I red blood cell antigens. Blood 1991, 78:2372-2386
35. Riboldi P, Gaidano G, Schettino EW, Steger TG, Knowles DM, Dalla Favera R, Casali P: Two acquired immunodeficiency syndrome-associated Burkitt's lymphomas produce specific anti-i IgM cold agglutinins using somatically mutated VH4-21 segments. Blood 1994, 83: 2952-2961
36. Levinson AI, Kozlowski L, Zheng Y, Wheatley L: B-cell-superantigens: definition and potential impact on the immune response. J Clin Immunol 1995, 15(suppl 6):26S-36S
37. Silverman GJ, Pires R, Bouvet JP: An endogenous scialoprotein and a bacterial B cell superantigen compete with their VH family-specific binding interactions with human Igs. J Immunol 1996, 157:4496-4502
38. Domiati-Saad R, Lipsky PE: Staphylococcal enterotoxin A induces survival of VM3-expressing human B cells by binding to the VH region with low affinity. J Immunol 1998, 161:1257-1266
39. Domiati-Saad R, Attrep JF, Brezinsche HP, Cherrie AH, Karp DR, Lipsky PE: Staphylococcal enterotoxin D functions as a human B cell superantigen by rescuing VH4-expressing B cells from apoptosis. J Immunol 1996, 156:3608-3620
40. Schroeder Jr HW, Hillson JL, Perlmutter RM: Early restriction of the human antibody repertoire. Science 1987, 238:791-793
41. Sasso EH, van Dijk KW, Bull AP, Milner ECB: A fetally expressed immunoglobulin VH1 gene belongs to a complex sets of alleles. J Clin Invest 1993, 91:2358-2367
42. Brezinschek HP, Brezinschek RI, Dorner T, Lipsky PE: Similar characteristics of the CDR3 of VH1-69/DP-10 rearrangements in normal human peripheral blood and chronic lymphocytic leukaemia B cells. Br J Haematol 1998, 102:516-521
43. Johnson TA, Rassenti LZ, Kipps TJ: VH1 genes expressed in B cell chronic lymphocytic leukemia exhibit distinctive molecular features. J Immunol 1997, 158:235-246
44. Gorevic PD, Frangione B: Mixed cryoglobulinemia crossreactive idiotypes: implication for the relationship of MC to rheumatic and lymphoproliferative disease. Semin Hematol 1991, 28:79-94
45. Agnello V: The etiology and pathophysiology of mixed cryoglobulinemia secondary to hepatitis C virus infection. Springer Semin Immunopathol 1997, 19:111-129
46. Ivanovski M, Silvestri F, Pozzatto G, Anand S, Mazzaro C, Burrone OR, Efremov DG: Somatic hypermutation, clonal diversity, and preferential expression of the VH 51p1/VL kv325 immunoglobulin gene combination in hepatitis C virus-associated immunocytomas. Blood 1998, 91:2433-2442
47. Miklos JA, Swerdlow SH, Bahler DW: Salivary gland mucosa-associated lymphoid tissue lymphoma immunoglobulin VH genes show frequent use of V1-69 with distinctive CDR3 features. Blood 2000, 95:3878-3884
48. Chan CH, Hadlock KG, Foung KH, Levy S: VH1-69 gene is preferentially used by hepatitis C virus-associated B cell lymphomas and by normal B cells responding to the E2 viral antigen. Blood 2001, 97: 1023-1026
49. Hussel T, Isaacson PG, Crabtree JE, Spencer J: The response of cells from low-grade B-cell gastric lymphoma of mucosa associated lymphoid tissue to Helicobacter pylori. Lancet 1993, 342:571-574
50. Greiner A, Marx A, Heesemann J, Leebmann J, Schmausser B, Muller-Hermelink HK: Idiotype identity in a MALT-type lymphoma and B-cell in Helicobacter pylori associated chronic gastritis. Lab Invest 1994, 70:572-578